ESHRE Position statements and papers
Statements, opinions, responses about recent highlights and milestones in the field of reproductive science and medicine can be found in this section .
EU legislation on Substances of Human Origin (SoHO)
January 2023 – ESHRE has welcomed the European Commission's proposal for a SoHO Regulation and actively voiced the views of MAR professionals on the elements of the proposal that should still be improved and clarified to ensure it brings maximum benefit to MAR patients, donors, and children born from MAR, as well as to professionals involved in MAR treatments.
European Health Data Space
October 2022 – ESHRE joined a group of 35 stakeholders in welcoming the European Commission’s proposal on the European Health Data Space and shares stakeholders’ recommendations on how to make the digital transformation a success across Europe.
Research and actions on infertility and MAR
June 2022 – ESHRE sets out several key topics related to infertility and MAR that should be considered for inclusion in research funding programmes, to advance the field of MAR as well as contribute to reducing the negative impacts of infertility.
Innovation
May 2022 – ESHRE puts forward recommendations for responsible innovation, aiming to improve access to innovations for MAR patients, while at the same time ensuring the efficacy and safety of treatments.
Registries
January 2022 - Europe needs registries to protect the intended parents, third-party donors and children born from Medically Assisted Reproduction
Revision of the EU legislation on Blood Tissues and Cells
June 2021 - ESHRE is actively involved to ensure that the specificities of medically assisted reproduction are considered and the voice of MAR professionals is heard in the revision of the EUTCD.
EU Tissues and cells directive
These position statements are directed at policy makers. For position statements directed at professionals, please go to this page